Hemostasis in abortion

  • R. C. Briel
Chapter
Part of the Advances in Reproductive Health Care book series (ARHE, volume 3)

Abstract

Hemostatic disorders in abortion are rare. However, when they occur they can lead to serious complications. Abortion curettage in the first trimester has a hemorrhage rate of 0.06% (Grimes and Gates, 1979). Increased blood loss is usually due to incomplete abortion, laceration, perforation or uterine atony rather than coagulation disorders (Moberg et al., 1975). Severe hemorrhage in itself can induce consumptive coagulopathy. No case of amniotic fluid embolism (AFE) in the first trimester of pregnancy has been reported so far (Guidotti et al., 1981).

Keywords

Disseminate Intravascular Coagulation Disseminate Intravascular Coagulation Hypertonic Solution Uterine Atony Amniotic Fluid Embolism 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Badraoui, M. H. H., Bonnar, J., Hillier, K. and Embrey, M. P. (1973). Blood coagulation changes during mid-trimester abortion induced by prostaglandin F2α. Br. Med. J., 4, 375–8PubMedCrossRefGoogle Scholar
  2. Bonnar, J. (1981). Haemostasis and coagulation disorders in pregnancy. In Bloom, A. L. and Thomas, D. P. (eds) Haemostasis and Thrombosis, pp. 454–71. (Edinburgh: Churchill Livingstone)Google Scholar
  3. Briel, R. C. and Lippert, T. H. (1981). Biological action and half Hfe in plasma of intramuscular sulprostone for termination of second trimester pregnancy. Prostaglandins Med., 6, 1–8PubMedCrossRefGoogle Scholar
  4. Briel, R. C., Kidess, E., Kunz, S. and Dieter, B. (1978a). Studies on platelet function during different modes of administration of PGF2α in obstetrics and gynecology. Arch. Gynäkol., 225, 201–8PubMedCrossRefGoogle Scholar
  5. Briel, R. C., Kunz, S. and Kidess, E. (1978b). Influence on haemostasis excercised by prostaglandin F2α in missed abortion. Geburtsh. Frauenheild. 38, 862–7Google Scholar
  6. Briel, R. C., Kunz, S. and Kidess, E. (1979). Platelet function, coagulation and fibrinolysis during termination of missed abortion and missed labor by PGF2α and oxytocin. Acta Obstet. Gynecol. Scand., 58, 361–4PubMedCrossRefGoogle Scholar
  7. Burkmann, R. T., Bell, W. R., Atienza, M. F. and King, T. M. (1977). Coagulopathy with midtrimester induced abortion: Association with hyperosmolar urea administration. Am. J. Obstet. Gynecol., 127, 533–6Google Scholar
  8. Carreras, L. D., Defreyn, G., Machin, S. J., Vermylen, J., Deman, R., Splitz, B. and van Assche, A. (1981). Arterial thrombosis, intrauterine death and “lupus” anticoagulant: detection of immunoglobulin interfering with prostacyclin formation. Lancet, 1, 244–6PubMedCrossRefGoogle Scholar
  9. Cohen, E. and Ballard, C. A. (1974). Consumptive coagulopathy associated with intraamniotic saline instillation and the effect of intravenous oxytocin. Obstet. Gynecol., 43, 300–3PubMedGoogle Scholar
  10. Egbring, R., Andrassy, K., Egli, H. and Mayer-Lindenberg, J. (1970). Untersuchungen bei zwei Patienten mit kongenitalem Faktor-XIII-Mangel. Thromb. Diathes. Haemorrh., 23, 313–39Google Scholar
  11. Grimes, D. A. and Cates, W., Jr. (1979). Complications from legally-induced abortion: a review. Obstet. Gynecol. Surv., 34, 177–91PubMedCrossRefGoogle Scholar
  12. Grimes, D. A., Cates, W., Jr. and Selik, R. M. (1981). Fatal septic abortion in the United States, 1975—1977. Obstet. Gynecol., 57, 739–44PubMedGoogle Scholar
  13. Guidotti, R. J., Grimes, D. A. and Cates, W., Jr. (1981). Fatal amniotic fluid embolism during legally induced abortion. United States, 1972 to 1978. Am. J. Obstet. Gynecol., 141, 257–61PubMedGoogle Scholar
  14. Hahn, L., Lundberg, P. A. and Teger-Nilsson, A. C. (1978). Congenital hypofibrinogenaemia and recurrent abortion. Br. J. Obstet. Gynaecol., 85, 790–3PubMedCrossRefGoogle Scholar
  15. Harman, Ch. R., Fish, D. G. and Tyson, J. E. (1981). Factors influencing morbidity in termination of pregnancy. Am. J. Obstet. Gynecol., 139, 333–7PubMedGoogle Scholar
  16. Howie, P. W. (1976). Prostaglandins and blood coagulation. In Karim, S. M. M. (ed.) Prostaglandins: Physiological, Pharmacological and Pathological Aspects, pp. 277-91. (Lancaster: MTP Press)Google Scholar
  17. Keirse, M. J. N. C., Bennebroek-Gravenhorst, J., Boekhout-Mussert, M. J., Dubbeldam, J. and Veltkamp, J. J. (1980). Coagulation changes during management of fetal death with 15 (S)-15-methylprostagladin F2α. Fur. J. Obstet. Gynecol. Reprod. Biol., 11, 43–8CrossRefGoogle Scholar
  18. Kidess, E., Briel, R. C., Miller, H. and Dieter, B. (1979a). Das Verhalten der Thrombozytenaggregation bei Schwangerschaftstermination wahrend des ersten Trimesters. Arch. Gynecol., 228, 629–30PubMedGoogle Scholar
  19. Kidess, E., Briel, R. C., Preissner, A. and Leipold, J. (1979b). Änderung der Faktor-XIII-Aktivität bei Schwangerschaftstermination mittels Saugkürettage. Arch. Gynecol., 228, 627PubMedGoogle Scholar
  20. Koplik, L. (1977). Disseminated intravascular coagulation after a dilatation and evacuation abortion at 16 weeks’ gestation. Annual Meeting, National Abortion Federation, Denver, ColoradoGoogle Scholar
  21. Kuhn, W. and Graeff, H. (eds.) (1979). Coagulation Disorders in Obsterics. (Stuttgart, New York: Thieme)Google Scholar
  22. Lerner, R., Marqolin, M., Slate, W. G. and Rosenfeld, H. (1967). Heparin in the treatment of hypofibrinogenemia complicating fetal death in utero. Am. J. Obstet. Gynecol., 97, 373–8PubMedGoogle Scholar
  23. MacKenzie, I. Z., Sayers, L., Bonnar, J. and Hillier, K. (1975). Coagulation changes during second-trimester abortion induced by intra-amniotic prostaglandin E2 and hypertonic solutions. Lancet, 2, 1066–9.PubMedCrossRefGoogle Scholar
  24. Moberg, P., Sjöberg, B. and Wiqvist, N. (1975). The hazards of vacuum aspiration in late first trimster abortions. Acta Obstet. Gynecol. Scand., 53, 113–18CrossRefGoogle Scholar
  25. Myatt, L. and Elder, M. G. (1975). The effects on platelet aggregation of oral prostaglandin E2 used for the induction of labour. Br. J. Obstet. Gynaecol., 82, 449–52PubMedCrossRefGoogle Scholar
  26. Ölund, A. R. and Bistoletti, P. (1980). Koagulations-und Fibrinoiysesystem bei Rivanolinduziertem Schwangerschaftsabbruch. Zbl Gynäcol., 102, 507–12Google Scholar
  27. Pfeifer, G. W. (1968). Proteinasenblockade bei abgestorbener Schwangerschaft, “dead fetus syndrome”. Dtsch. Med. Wochenschr., 93, 479–85PubMedCrossRefGoogle Scholar
  28. Pritchard, J. A. and MacDonald, P. C. (eds) (1976). Williams Obstetrics, pp. 426–8. (New York: Appleton-Century-Crofts)Google Scholar
  29. Schander, K., Budde, U. and Bellmann, O. (1979). Untersuchungen zum Verhalten der plasmatischen Gerinnung und der Thrombozytenfunktion bei der Abortinduktion mit dem Prostaglandin E2-Derivat Sulproston. Arch. Gynecol., 228, 635–7PubMedGoogle Scholar
  30. Shaw, S. T., Jr. and Ballard, C. A. (1974). Subclinical coagulopathy following amnioinfusion with hypertonic saline. Am. J. Obstet. Gynecol., 118, 1081–8PubMedGoogle Scholar
  31. Sromme, W. B. and Fromke, V. L. (1978). Amniotic fluid embolism and disseminated intravascular coagulation after evacuation of missed abortion. Obstet. Gynecol., 52, 1 (Suppl.), 76–80Google Scholar
  32. Talbert, L. M. and Blatt, P. M. (1979). Disseminated intravascular coagulation in obstetrics. Clin. Obstet. Gynaecol., 22, 889–900CrossRefGoogle Scholar

Copyright information

© MTP Press Limited 1984

Authors and Affiliations

  • R. C. Briel

There are no affiliations available

Personalised recommendations